Zdrowie i gospodarka · 16/10/2020
FDA Reopens Comment Period for Patent Information in Orange Book
The FDA is reopening the comment period for a notice regarding the listing of patent information in the Orange Book, a publication that lists approved drugs, after receiving a request for an extension to allow more time for public comments.